Similar to large and small molecule drugs, bioelectronic medicine therapies act through targeted mechanisms of action to treat diseases. Specifically, certain bioelectronic devices can trigger the release of endogenous neurotransmitters to affect immune-mediated and receptor-mediated pathways.